April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Retinal reperfusion following panretinal photocoagulation for diabetic retinopathy
Author Affiliations & Notes
  • Tsuneaki Omae
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • Taiji Nagaoka
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • Akitoshi Yoshida
    Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  • Footnotes
    Commercial Relationships Tsuneaki Omae, None; Taiji Nagaoka, None; Akitoshi Yoshida, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3899. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tsuneaki Omae, Taiji Nagaoka, Akitoshi Yoshida; Retinal reperfusion following panretinal photocoagulation for diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3899.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

It has reported that reperfusion after pan retinal photocoagulation (PRP) occurred in some eyes with retinal nonperfusion area (NPA) of diabetic retinopathy. However, the contribution of reperfusion to progression of diabetic retinopathy remains unclear. The purpose of this study was to examine the incidence and impact of retinal reperfusion following PRP for proliferative diabetic retinopathy (PDR) using fluorescein angiograms (FA)

 
Methods
 

This study included 37 patients (54 eyes) with early PDR presenting with extensive range of retinal NPA in fluorescein angiographic findings and who was received PRP in our hospital between March 2008 and May 2013 with a minimum follow-up of 6 months. Their ages ranged from 35 to 77, average 58 years. FA was performed before and 2 months after PRP for evaluation of the reperfusion in retinal areas. The eyes were divided into 2 groups on the basis of the presence and absence of reperfusion and further the eyes of each group were evaluated regarding incidence of vitreous hemorrhage (VH) required vitrectomy. The eyes with residual NPA after PRP were also divided into two groups according to region where the residual NPA of retina was observed: posterior pole and midperiphery of the retina. The eyes of each group were evaluated regarding incidence of VH required vitrectomy.

 
Results
 

After PRP, reperfusion was observed in 18 eyes (Reperfusion-group) and no reperfusion was observed in 36 eyes (No-Reperfusion group). In the No-Reperfusion group, 7 of 36 eyes (19%) was required vitrectomy due to VH, whereas no eye was required vitrectomy in the Reperfusion group (p=0.045). Among 36 eyes in No-Reperfusion group, 8 eyes showed NPA at the posterior pole (P group) and 28 eyes showed at the midperiphrey (M group). Vitrectomy was required due to VH in 2 eyes in P group and 5 eyes in M group (p=0.65).

 
Conclusions
 

In patients with early proliferative diabetic retinopathy, the incidence of VH required vitrectomy was higher in eyes with no reperfusion in NPA after PRP.

 
Keywords: 498 diabetes • 688 retina • 499 diabetic retinopathy  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×